Treatment Sequencing in Advanced Bladder Cancer After Enfortumab Vedotin and Pembrolizumab

Speaker(s)

• 

  Daniele Raggi

  Consultant Medical Oncologist
  The Royal Marsden Foundation Trust, United Kingdom